Impact of estrogen receptor expression level on response to neoadjuvant chemotherapy and prognosis in HER2-negative breast cancers

Impact of estrogen receptor expression level on response to neoadjuvant chemotherapy and prognosis in HER2-negative breast cancers

Abstract Background Breast cancers with 1–10% cell staining for estrogen receptor (ER) present particular clinical features. The clinical data of estrogen receptor expression level and treatment effect are limited, particularly regarding chemotherapy benefit. We evaluated the pathologic response to...

ver descrição completa

Detalhes bibliográficos
Principais autores: Hai-long Chen, Feng-bo Huang, Qiang Chen, Yong-chuan Deng
Formato: Artigo
Idioma:English
Publicado em: BMC 2023-09-01
coleção:BMC Cancer
Assuntos:
Breast cancer
Estrogen receptor
Neoadjuvant chemotherapy
Pathologic complete response
Prognosis
Acesso em linha:https://doi.org/10.1186/s12885-023-11368-2

Registros relacionados

Registros relacionados